EUVIMEDEUVIMED entdecken
Crossref

Mechanism Exploration of Dietary Supplement Astaxanthin on Improving Atherosclerosis through an Integrated Strategy Encompassing Artificial Intelligence Virtual Screening and Experimental Validation

Yisa Cai, Shiyan Yang, Jiajiang Zhao, Guangzhen Zheng, Yun Han iD, Yuhan Zhang, Yiyuan Qin, Chao Yang, Qingping Xiong, Xinyi Chu, Chunhan Ju, Huixia Yin und 4 weitere

Journal of Agricultural and Food Chemistry · 2025

DOI: 10.1021/acs.jafc.4c11894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Yisa Cai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Huaiyin Institute of Technology, Huai'an 223003, Jiangsu, P. R. C…. Hauptthemen laut MEDLINE: Atherosclerosis, Dietary Supplements. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, Graduate Research and Innovation Projects of Jiangsu Province, Jiangsu Key Laboratory of Regional Resource Exploitation and Medicinal Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a major and common pathological basis of ischemic intestinal infarction, myocardial infarction, stroke, renal failure, and other highly lethal and disabling diseases. Current pharmacological interventions (e.g., statins) often cause adverse effects, limiting their long-term use. Natural compounds, with their multitarget efficacy and superior safety profiles, have emerged as promising alternatives for AS treatment. As a potent antioxidant carotenoid, astaxanthin exhibits unique therapeutic potential by simultaneously targeting inflammation, oxidative stress, and lipid metabolism, which are key drivers of AS pathogenesis. This study will systematically decipher astaxanthin's therapeutic mechanisms through an integrative strategy encompassing artificial intelligence virtual screening and experimental validation. Notably, five proteins, including CTSD, DPP4, FABP5, ITGAL, and MMP9, were identified as core targets for astaxanthin intervention in AS via network pharmacology and machine learning. Meanwhile, the results from molecular dynamic simulations confirmed that these core targets can stable binding with astaxanthin. Furthermore, in vitro experiments further validated astaxanthin can inhibit foam cell formation, restore redox balance, and suppress inflammation. Moreover, a close correlation has been found between them. These findings position astaxanthin as a multitarget natural agent to combat AS, addressing both efficacy advantage and safety concerns of current therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisDietary SupplementsXanthophyllsHumansArtificial IntelligenceAnimalsOxidative StressMolecular Dynamics SimulationAntioxidantsMice

Stichwörter der Autor:innen

astaxanthinatherosclerosisdietary supplementoxidative stress-inflammation axisvirtual screening

Substanzen

astaxanthineXanthophyllsAntioxidants

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Huaiyin Institute of Technology, Huai'an 223003, Jiangsu, P. R. China.
  • Translational Institute for Cancer Pain, Chongming Hospital Affiliated to Shanghai University of Health & Medicine Sciences (Xinhua Hospital Chongming Branch), Shanghai 202155, P. R. China.
  • Department of Internal Medicine, Huaian Hospital Affiliated to Xuzhou Medical University, Huai'an 223002, Jiangsu, P. R. China.
  • Yunnan Hongqingfu Biotechnology Co., LTD., Kunming 650000, Yunnan, P. R. China.
  • School of Traditional Chinese Medicine, Binzhou Medical University, Yantai 264003, Shandong, P. R. China.
  • Department of Cardiology, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huai'an 223000, Jiangsu, P. R. China.

ORCID-Profile: Yun Han, Yingying Shi

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • Graduate Research and Innovation Projects of Jiangsu Province
  • Jiangsu Key Laboratory of Regional Resource Exploitation and Medicinal Research
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Project of Science and Technology Development of Traditional Chinese Medicine in Jiangsu Province of China
  • Anhui Province
  • Huai'an City

Zitieren

APA

Cai, Y., Yang, S., Zhao, J., Zheng, G., Han, Y., Zhang, Y., Qin, Y., Yang, C., Xiong, Q., Chu, X., Ju, C., Yin, H., Shi, Y., Jiang, F., Yong, H., & Zhu, Y. (2025). Mechanism Exploration of Dietary Supplement Astaxanthin on Improving Atherosclerosis through an Integrated Strategy Encompassing Artificial Intelligence Virtual Screening and Experimental Validation. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.4c11894

Vancouver

Cai Y, Yang S, Zhao J, Zheng G, Han Y, Zhang Y, et al. Mechanism Exploration of Dietary Supplement Astaxanthin on Improving Atherosclerosis through an Integrated Strategy Encompassing Artificial Intelligence Virtual Screening and Experimental Validation. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.4c11894

BibTeX
@article{Cai2025,
  author = {Cai, Yisa and Yang, Shiyan and Zhao, Jiajiang and Zheng, Guangzhen and Han, Yun and Zhang, Yuhan and Qin, Yiyuan and Yang, Chao and Xiong, Qingping and Chu, Xinyi and Ju, Chunhan and Yin, Huixia and Shi, Yingying and Jiang, Feng and Yong, Hui and Zhu, Yong},
  title = {Mechanism Exploration of Dietary Supplement Astaxanthin on Improving Atherosclerosis through an Integrated Strategy Encompassing Artificial Intelligence Virtual Screening and Experimental Validation},
  journal = {Journal of Agricultural and Food Chemistry},
  year = {2025},
  doi = {10.1021/acs.jafc.4c11894}
}
Kostenlos starten →